LXRX insider buying and SEC filings, explained
Lexicon Pharmaceuticals, Inc. · CIK 1062822
Tracked: Forms 3/4/5, 8-K, NT · All filings on sec.gov
Insider activity in the last 12 months
Bought
$720K
Insiders who bought
1
Sold (not marked 10b5-1)
$0
Planned sales (10b5-1)
$0
Insider purchases and sales, last 12 months
| Traded | Type | What was filed | Source |
|---|---|---|---|
| Feb 25, 2026 | Purchase (code P) | Raymond Debbane (Director) bought 2,000 shares at $1.49 ($3K), reported as a purchase (code P). Holdings up <1% to 1,906,186 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Feb 27, 2026 |
| Feb 23, 2026 | Purchase (code P) | Raymond Debbane (Director) bought 100,000 shares at $1.47 ($147K), reported as a purchase (code P). Holdings up 6% to 1,904,186 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Feb 25, 2026 |
| Feb 19–20, 2026 | Purchase (code P) | Raymond Debbane (Director) bought 150,000 shares between Feb 19 and Feb 20 at about $1.47 ($220K), reported as a purchase (code P). Holdings up 9% to 1,804,186 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Feb 23, 2026 |
| Feb 13–18, 2026 | Purchase (code P) | Raymond Debbane (Director) bought 268,497 shares between Feb 13 and Feb 18 at about $1.31 ($353K), reported as a purchase (code P). Holdings up 19% to 1,654,186 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Feb 18, 2026 |
| Feb 2, 2026 | Other purchase | Raymond Debbane (Director) bought 1,538,462 Common Stock indirectly at $1.30 ($2.0M) in a public offering. New position of 1,538,462 shares. Not marked as a 10b5-1 plan trade. Filed jointly with 8 other reporting owners. | SEC filing Filed Feb 4, 2026 |
33 routine transactions (such as grants, option exercises or tax withholding) are not listed.
Cluster buys
No cluster buys in the last 12 months.
Red flags
No red flags in the last 12 months.
Key events
No key events in the last 12 months.
8-K filings, last 12 months
No 8-K filings in the last 12 months.
Red flags are objective triggers only: the item or form filed, never an opinion.
Follow LXRX in the Insider Ledger app
Get the appA plain-English brief of insider purchases, 8-Ks and red flags at the companies you pick. No account needed.